MICROENCAPSULATION OF INDONESIAN POLYMER BIODIVERSITY IN WARTHON'S JELLY MESENCHYMAL STEM CELL (WJMSC)

Authors

  • DENI RAHMAT Faculty of Pharmacy, Pancasila University, Jl Srengseng Sawah, Jagakarsa, South Jakarta 12640, Indonesia
  • WAHYU WIDOWATI Faculty of Medicine, Maranatha Christian University, Jl Surya Sumantri No 65, Bandung 40164, West Java, Indonesia
  • AHMAD FARIED Department of Neurosurgery and, Oncology and Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
  • ITA MARGARETHA NAINGGOLAN Faculty of Medicine and Health Sciences, Atma Jaya Catholic University, Jl. Jenderal Sudirman No.51, South Jakarta 12930, Indonesia
  • DIDIK PRIYANDOKO Faculty of Mathematic and Natural Science Education, Indonesia University of Education, Jl. Dr. Setiabudi No. 229, Bandung 40154, West Java, Indonesia
  • ANARISA BUDIATI Faculty of Pharmacy, Pancasila University, Jl Srengseng Sawah, Jagakarsa, South Jakarta 12640, Indonesia
  • TEDDY MARCUS ZAKARIA Faculty of Information Technology, Maranatha Christian University, Jl. Surya Sumantri No 65, Bandung 40164, West Java, Indonesia
  • ERVI AFIFAH PT Aretha Medika Utama, Jl. Babakan Jeruk II No. 9, Bandung 40163, West Java, Indonesia

DOI:

https://doi.org/10.22159/ijap.2022.v14s3.19

Keywords:

WJMSC, Microencapsulation, Polymers, Stem cells, Drug delivery

Abstract

Objective: WJMSC is a stem cell-derived from Wharton's Jelly the umbilical cord of pregnant women which has the ability to differentiate into other cells that are osetogenic, myogenic, neurogenic, and hematopoietic. Stem cell microencapsulation is a cell coating technique that is expected to act as a delivery vehicle. This study aims to make stem cell microencapsulation using various types of natural polymers.

Methods: WJMSC (Wharton's Jelly Mesenchymal Stem Cell) was cultured with supplemented Modified Eagle Medium (MEM) Alpha in incubator with 37 °C and 5% of CO2. In this study, we investigated various of natural polymers (chitosan, glucomannan, inulin, fucoidan and amylopectin) in WJMSC microencapsulation. Viability cell of WJMSC microencapsulate was measured using MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay, and the condition medium (CM) was determined the measure EGF, IL-6, VEGF with ELISA.

Results: WJMSC microencapsulation using chitosan, oxidized glucomannan, inulin, fucoidan and oxidized amylopectin showed viability cell up to 100%. The EGF, IL-6, VEGF levels were increased in all tested polymers compared to negative control.

Conclusion: Tested polymers (chitosan, oxidized glucomannan, inulin, fucoidan, oxidized amylopectin) were not toxic to WJMSC and cell microencapsulation was successfully carried out.

Downloads

Download data is not yet available.

References

Widowati W, Wijaya L, Murti H, Widyastuti H, Agustina D, Laksmitawati DR. Conditioned medium from normoxia (WJMSCs-norCM) and hypoxia-treated WJMSCs (WJMSCs-hypoCM) in inhibiting cancer cell proliferation. Biomark Genom Med. 2015;7(1):8-17. doi: 10.1016/j.bgm.2014.08.008.

Widowati W, Rihibiha DD, Khiong K, Widodo MA, Sumitro SB, Bachtiar I. Hypoxia in mesenchymal stem cell. Hypox Hum Dis. 2017;1:91-115.

Kusuma GD, Frith JE, Sobey CG, Lim R. Editorial: Stem cells as targeted drug delivery vehicles. Front Pharmacol. 2020;11:614730. doi: 10.3389/fphar.2020.614730, PMID 33408635.

Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long‐term cellular therapy. FASEB J. 2010;24(1):22-31. doi: 10.1096/fj.09-131888, PMID 19726759.

Barminko J, Kim JH, Otsuka S, Gray A, Schloss R, Grumet M. Encapsulated mesenchymal stromal cells for in vivo transplantation. Biotechnol Bioeng. 2011;108(11):2747-58. doi: 10.1002/bit.23233, PMID 21656712.

Widowati W, Noverina R, Ayuningtyas W, Kurniawan D, Kusuma HSW, Arumwardana S. Proliferation, characterization and differentiation potency of adipose tissue-derived mesenchymal stem cells (AT-MSCs) cultured in fresh frozen and non-fresh frozen plasma. Int J Mol Cell Med. 2019;8(4):283-94. doi: 10.22088/IJMCM.BUMS.8.4.283, PMID 32587838.

Kosaraju R, Rennert RC, Maan ZN, Duscher D, Barrera J, Whittam AJ. Adipose-derived stem cell-seeded hydrogels increase endogenous progenitor cell recruitment and neovascularization in wounds. Tissue Eng Part A. 2016;22(3-4):295-305. doi: 10.1089/ten.tea.2015.0277, PMID 26871860.

Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106-26. doi: 10.1016/j.progpolymsci.2011.06.003, PMID 22125349.

Siti Ismail N, Bishop AE, Polak JM, Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials. 2008;29(29):3946-52. doi: 10.1016/j.biomaterials.2008.04.027, PMID 18639332.

Swioklo S, Connon CJ. Keeping cells in their place: the future of stem cell encapsulation. Expert Opin Biol Ther. 2016;16(10):1181-3. doi: 10.1080/14712598.2016.1213811, PMID 27414089.

Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(5):1496. doi: 10.3390/ijms19051496, PMID 29772777.

Lister INE, Ginting CN, Girsang E, Amansyah A, Chiuman L, Yanti NLWE. Hepatoprotective effect of eugenol on acetaminophen-induced hepatotoxicity in HepG2 cells. J Phys: Conf Ser. 2019;1374(1):012009. doi: 10.1088/1742-6596/1374/1/012009.

Luo R, Wang Y, Xu P, Cao G, Zhao Y, Shao X. Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin Type I domain containing 7A. Sci Rep. 2016;6:19588. doi: 10.1038/srep19588, PMID 26796133.

Zhang WJ, Li BG, Xie XH, Zhang C, Tang TT. Preparation of MSCs alginate-based microcapsules for gene therapy. IEEE Publications; 2007. p. 196-9.

Sandhiutami NM, Moordiani M, Laksmitawati DR, Fauziah N, Maesaroh M, Widowati W. In vitro assesment of anti-inflammatory activities of coumarin and Indonesian cassia extract in RAW 264.7 murine macrophage cell line. Iran J Basic Med Sci. 2017;20(1):99-106. doi: 10.22038/ijbms.2017.8102, PMID 28133531.

Noverina R, Widowati W, Ayuningtyas W, Kurniawan D, Afifah E, Laksmitawati DR. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Clin Nutr Exp. 2019;24:34-44. doi: 10.1016/j.yclnex.2019.01.002.

Peniche C, Arguelles Monal W, Peniche H, Acosta N. Chitosan: an attractive biocompatible polymer for microencapsulation. Macromol Biosci. 2003;3(10):511-20. doi: 10.1002/ mabi.200300019.

Tamama K, Kerpedjieva SS. Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells. Adv Wound Care. 2012;1(4):177-82. doi: 10.1089/wound.2011.0296, PMID 24527301.

Published

28-06-2022

How to Cite

RAHMAT, D., WIDOWATI, W., FARIED, A., NAINGGOLAN, I. M., PRIYANDOKO, D., BUDIATI, A., ZAKARIA, T. M., & AFIFAH, E. (2022). MICROENCAPSULATION OF INDONESIAN POLYMER BIODIVERSITY IN WARTHON’S JELLY MESENCHYMAL STEM CELL (WJMSC). International Journal of Applied Pharmaceutics, 14(3), 91–94. https://doi.org/10.22159/ijap.2022.v14s3.19

Issue

Section

Original Article(s)

Most read articles by the same author(s)

1 2 > >>